Inventor · disambiguated record
Ngeh J. Toyang
Also filed as: TOYANG NGEH J · TOYANG NGEH JOSEPH
9 granted patents·8 pending applications·12 citations·filing 2011–2021
81Inventor score
Top patents by PatentIndex Score
17 records- 0188US9687469B2Agent containing flavonoid derivatives for treating cancer and inflammationLOWE HENRY·Filed 2015·Granted Jun 27, 2017·5 cites·1 claims
- 0283US10398674B2Therapeutic agents containing cannabis flavonoid derivatives targeting kinases, sirtuins and oncogenic agents for the treatment of cancersFLAVOCURE BIOTECH LLC·Filed 2015·Granted Sep 3, 2019·4 cites·2 claims
- 0380US10278950B2Therapeutic agents containing cannabis flavonoid derivative for ocular disordersLOWE HENRY I C·Filed 2016·Granted May 7, 2019·2 cites·2 claims
- 0476US10765660B2Agent containing flavonoid derivatives for treating cancer and inflammationLOWE HENRY·Filed 2017·Granted Sep 8, 2020·1 cites·7 claims
- 0572US11141401B2Therapeutic agents containing cannabis flavonoid derivatives targeting kinases, sirtuins and oncogenic agents for the treatment of cancersLOWE HENRY·Filed 2019·Granted Oct 12, 2021·0 cites·10 claims
- 0671US2020253918A1Therapeutic agents containing cannabis flavonoid derivatives targeting kinases, sirtuins and oncogenic agents for the treatment of cancersLOWE HENRY·Filed 2019·Application pending·0 cites
- 0766US2021121437A1Therapeutic agents containing cannabis flavonoid derivatives targeting kinases, sirtuins and oncogenic agents for the treatment of multiple myeloma, lymphoma, and leukemiaLOWE HENRY·Filed 2020·Application pending·0 cites
- 0863US10632098B2Therapeutic agents containing cannabis flavonoid derivative for ocular disordersLOWE HENRY I C·Filed 2019·Granted Apr 28, 2020·0 cites·8 claims
- 0960US2020016094A1Therapeutic cannabinoid derivatives composition as histamine 2 (h2) blocking agentsLOWE HENRY·Filed 2019·Application pending·0 cites
- 1060US2021369642A1Therapeutic cannabinoid derivatives composition as histamine 2 (h2) blocking agentsLOWE HENRY·Filed 2021·Application pending·0 cites
- 1158US10912740B2Treating hepatitis C with cannabidiolLOWE HENRY·Filed 2018·Granted Feb 9, 2021·0 cites·16 claims
- 1252US2018353462A1Therapeutic agents containing cannabis flavonoid derivatives targeting kinases, sirtuins and oncogenic agents for the treatment of cancersLOWE HENRY·Filed 2016·Application pending·0 cites
- 1349US2021346339A1Therapeutic flavonoid based antiviral agentsLOWE HENRY C·Filed 2021·Application pending·0 cites
- 1443US10751320B2Therapeutic agents containing cannabis flavonoid derivatives for the prevention and treatment of neurodegenerative disordersFLAVOCURE BIOTECH LLC·Filed 2016·Granted Aug 25, 2020·0 cites·5 claims
- 1542US9814747B2Methods for inhibiting HIV-1 activity by inhibitory mechanisms of extracts of Guaiacum officinale L. (zygophyllaceae)LOWE HENRY·Filed 2015·Granted Nov 14, 2017·0 cites·9 claims
- 1642US2019358196A1Pi 4-kinase inhibitor as a therapeutic for viral hepatitis, cancer, malaria. autoimmune disorders and inflammation, and a radiosensitizer and immunosuppressantLOWE HENRY C·Filed 2017·Application pending·0 cites
- 1741US2012213766A1Anticancer Compounds from Vernonia GuineensisTOYANG NGEH JOSEPH·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ngeh J. Toyang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →